Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)

NCT05261126

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Westside Medical Associates of Los Angeles ( Site 0026) Beverly Hills, California, United States
  • Clinical Trials Research ( Site 0007) Sacramento, California, United States
  • National Research Institute (NRI) - Santa Ana ( Site 0024) Santa Ana, California, United States
  • Excel Medical Clinical Trials ( Site 0042) Boca Raton, Florida, United States
View all 63 locations
View Trial Details
Completed

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

NCT02808403

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Inuyama, Aichi-ken, Japan
  • Research Site Kasugai, Aichi-ken, Japan
View all 138 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

NCT04233918

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Wilmington, Delaware, United States
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site Kansas City, Kansas, United States
  • Regeneron Research Center Boston, Massachusetts, United States
View Trial Details
Completed

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)

NCT02624869

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +11 more
Locations
  • Research Site The Bronx, New York, United States
  • Research Site Cincinnati, Ohio, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Camperdown, New South Wales, Australia
View all 46 locations
View Trial Details

Related conditions